Get the Stockscreener App
1.28
2.29%
-0.03
After Hours:
1.26
-0.02
-1.56%
Elutia Inc stock is traded at $1.28, with a volume of 405.46K.
It is down -2.29% in the last 24 hours and down -35.68% over the past month.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$1.31
Open:
$1.31
24h Volume:
405.46K
Relative Volume:
5.76
Market Cap:
$48.74M
Revenue:
$24.38M
Net Income/Loss:
$-53.95M
P/E Ratio:
-0.5182
EPS:
-2.47
Net Cash Flow:
$-23.31M
1W Performance:
-31.91%
1M Performance:
-35.68%
6M Performance:
-58.84%
1Y Performance:
-70.57%
1-Day Range:
$1.28
$1.37
1-Week Range:
$1.28
$2.04
52-Week Range:
$1.28
$5.12
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
1.28 | 57.66M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
How moving averages guide Elutia Inc. tradingJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser
Published on: 2025-09-12 16:40:25 - Newser
What’s the recovery path for long term holders of Elutia Inc.July 2025 Macro Moves & Safe Entry Momentum Tips - Newser
Can swing trading help recover from Elutia Inc. lossesJuly 2025 Market Mood & AI Based Buy/Sell Signal Reports - Newser
Lake Street Capital Issues Pessimistic Forecast for Elutia (NASDAQ:ELUT) Stock Price - MarketBeat
What momentum shifts mean for Elutia Inc.Quarterly Profit Review & Real-Time Buy Signal Alerts - Newser
Strategies to average down on Elutia Inc.2025 Dividend Review & Free Daily Entry Point Trade Alerts - Newser
What earnings revisions data tells us about Elutia Inc.July 2025 Market Mood & AI Powered Market Entry Strategies - Newser
How to read the order book for Elutia Inc.2025 Sector Review & Community Consensus Trade Alerts - Newser
Price momentum metrics for Elutia Inc. explainedTrade Volume Summary & Growth Focused Stock Reports - Newser
Is Elutia Inc. stock poised for growthWeekly Market Outlook & Technical Confirmation Trade Alerts - Newser
What to do if you’re stuck in Elutia Inc.Trade Volume Report & High Conviction Trade Alerts - Newser
why elutia inc. stock attracts strong analyst attentionEntry Point & Entry Point Confirmation Alerts - Newser
Will Elutia Inc. stock go up soonWeekly Stock Report & High Return Trade Guides - Newser
Analyzing Elutia Inc. with multi timeframe chartsAnalyst Downgrade & Stock Portfolio Risk Control - Newser
Ranking Elutia Inc. among high performing stocks via toolsQuarterly Investment Review & Entry and Exit Point Strategies - Newser
How to use Fibonacci retracement on Elutia Inc.Market Performance Recap & Fast Gaining Stock Strategy Reports - Newser
How to forecast Elutia Inc. trends using time seriesWeekly Stock Summary & Consistent Growth Equity Picks - Newser
Elutia to divest bioenvelopes business to Boston Scientific for $88m - MSN
Sentiment analysis tools applied to Elutia Inc.2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - Newser
Alyeska Investment Group L.P. Has $6.69 Million Position in Elutia Inc. $ELUT - MarketBeat
How to escape a deep drawdown in Elutia Inc.Weekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Candlestick signals on Elutia Inc. stock todayWeekly Stock Analysis & Daily Price Action Insights - Newser
Elutia Sells Device Business to Boston Scientific - MSN
Detecting price anomalies in Elutia Inc. with AITrade Exit Report & Safe Capital Growth Plans - Newser
Boston Scientific to acquire Elutia’s bioenvelope biz for USD 88M - Medical Buyer
Boston Scientific Corporation to acquire Elutia’s bioenvelope biz for USD 88M - Medical Buyer
Lake Street Maintains Elutia(ELUT.US) With Buy Rating, Cuts Target Price to $6 - 富途牛牛
Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M - Cardiovascular Business
Boston Scientific buys Elutia's bioenvelope business for $88 million - MSN
Boston Scientific inks $88M Elutia deal to challenge Medtronic - MedTech Dive
Elutia : H.C. Wainwright 27th Annual Global Investment Conference Presentation - MarketScreener
Down 25.9% in 4 Weeks, Here's Why ELUTIA INC (ELUT) Looks Ripe for a Turnaround - Nasdaq
Elutia price target lowered to $6 from $8 at Lake Street - TipRanks
Lacklustre Performance Is Driving Elutia Inc.'s (NASDAQ:ELUT) 27% Price Drop - 富途牛牛
Strategic Acquisition of Elutia’s Bioenvelope Products Boosts Boston Scientific’s Market Position - TipRanks
Elutia Inc. stock momentum explainedGap Down & Entry and Exit Point Strategies - Newser
Using RSI to spot recovery in Elutia Inc.Risk Management & Verified Short-Term Trading Plans - Newser
how to forecast elutia inc. trends using time seriesJuly 2025 Movers & Verified Chart Pattern Trade Signals - Newser
Can Elutia Inc. rally from current levelsMarket Performance Summary & Precise Swing Trade Alerts - Newser
Can a trend reversal in Elutia Inc. lead to recoveryInsider Buying & Step-by-Step Swing Trade Plans - Newser
Boston Sci acquires Elutia's bioenvelopes for $88M - BioWorld MedTech
Big Gains And Big Losses Shape A Busy Day For Healthcare Stocks - Finimize
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million - citybiz
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):